DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Halal Pharmaceuticals Market Analysis & Trends - Product Type, Drug Classes, Source Material - Forecast to 2025" report to their offering.
Some of the prominent trends that the market is witnessing include growing need for certified medicines is propelling regulatory convergence, increasing awareness on satisfying religious needs, recent technological developments of halal pharmaceuticals, and growth opportunities/investment opportunities.
Based on Product type the market is categorized into capsules, tablets, syrups, and other product types. As per Source material the market is segmented into synthetic and semi-synthetic sources, animals, recombinant DNA, and plant and plant derivatives. By Drug Class the market is segregated into endocrine drugs, allergies, respiratory drugs, pain medications, cardiovascular drugs, and other drug classes.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
- Chemical Company of Malaysia Berhad
- EMBIL Pharmaceutical Co., Ltd
- Nutramedica Incorporated
- Pharmaniaga Bhd
Simpor Pharma Sdn Bhd
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Halal Pharmaceuticals Market, By Product Type
5 Halal Pharmaceuticals Market, By Source Material
6 Halal Pharmaceuticals Market, By Drug Classes
7 Halal Pharmaceuticals Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/t7k749/global_halal